Arvaya Healthcare Ltd
Arvaya Healthcare Ltd (ARVAYA) last reported results for the quarter ended Jun 2026, with sales of ₹29.91 crore and net profit of ₹0.53 crore. The stock last traded at ₹118, a market capitalisation of ₹565 crore, on a P/E of 425. Over the past 52 weeks the stock has ranged between ₹47.7 and ₹145. Figures are as of 6 Oct 2026 and are not real time.
Arvaya Healthcare Ltd share price and key metrics
- Current price
- ₹118
- Market cap
- ₹565 cr
- Stock P/E
- 425
- ROE
- %
- ROCE
- %
- Dividend yield
- 0.00%
- 52w high / low
- 145/47.7
Metrics as of 6 Oct 2026. Not real time.
Track Arvaya Healthcare Ltd
Cruxal reads every Arvaya Healthcare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Arvaya Healthcare Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- %
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- %
- 10 Years
- %
- 5 Years
- 40%
- 3 Years
- 78%
- 1 Year
- 159%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- Last Year
- %
Arvaya Healthcare Ltd quarterly results
| ₹ crore | Jun 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| Sales | 0 | 9.11 | 29.91 |
| Expenses | 0.28 | 7.73 | 25.95 |
| Operating profit | -0.28 | 1.38 | 3.96 |
| OPM % | — | 15.15% | 13.24% |
| Other income | 0.03 | 1.3 | 0.19 |
| Interest | 0 | 0.41 | 1.39 |
| Depreciation | 0 | 0.62 | 2.2 |
| Profit before tax | -0.25 | 1.65 | 0.56 |
| Tax % | 0.00% | 11.52% | 5.36% |
| Net profit | -0.25 | 1.47 | 0.53 |
| EPS (₹) | -0.33 | 0.26 | 0.08 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Arvaya Healthcare Ltd annual results
| ₹ crore | Mar 2026 |
|---|---|
| Sales | 9.11 |
| Operating profit | 0.72 |
| OPM % | 7.90% |
| Net profit | 0.9 |
| EPS (₹) | 0.15 |
TTM is the trailing twelve months to the most recent quarter.
Arvaya Healthcare Ltd cash flow
| ₹ crore | Mar 2026 |
|---|---|
| Cash from operations | -3.28 |
| Cash from investing | -7.03 |
| Cash from financing | 8.50 |
| Net cash flow | -1.81 |
| Free cash flow | -7.94 |
| CFO / operating profit | -456% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Arvaya Healthcare Ltd shareholding pattern
Promoters held 30.62% at Jun 2026, down from 63.10% at Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 7.74% | 7.74% | 7.74% | 63.10% | 62.73% | 62.73% | 30.62% | 30.62% |
| Public | 92.26% | 92.26% | 92.26% | 36.90% | 37.27% | 37.27% | 69.39% | 69.38% |
| No. of shareholders | 3,195 | 3,195 | 3,195 | 3,197 | 3,196 | 3,193 | 3,387 | 3,393 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Arvaya Healthcare Ltd corporate filings
- Closure of Trading window for the approval of unaudited financials statements Quarter and half year ended September 30, 2026.Insider Trading / SASTlow impact
- Arvaya Healthcare Limited shareholders approve acquisition of IP portfolio from DEFIB Institute of Health Solutions LLP at 41st AGMAGM/EGMmedium impact
Cruxal's analysis: Arvaya Healthcare Limited has successfully concluded its 41st Annual General Meeting…
Read the full analysis - Arvaya Healthcare Limited Announces Strategic Expansion via Subsidiary Incorporation, Acquisition, and Rights IssueAGM/EGMhigh impact
Cruxal's analysis: Arvaya Healthcare Limited (formerly Bijoy Hans Limited) has outlined a multi-pronged…
Read the full analysis - Arvaya Healthcare Ltd incorporates new wholly owned subsidiaryCompany Updatelow impact
Cruxal's analysis: Arvaya Healthcare Ltd has received the Certificate of Incorporation for a new wholly…
Read the full analysis - Arvaya Healthcare Limited Announces 41st Annual General Meeting (AGM) for September 21, 2026Company Updatelow impact
Cruxal's analysis: Arvaya Healthcare Limited has issued a formal notice for its 41st Annual General Meeting…
Read the full analysis - Arvaya Healthcare Limited Schedules 41st Annual General Meeting for 21st September 2026Company Updatelow impact
Cruxal's analysis: Arvaya Healthcare Limited has issued a formal notice for its 41st Annual General Meeting…
Read the full analysis - Arvaya Healthcare Ltd files 41st Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Arvaya Healthcare Ltd has submitted its 41st Annual Report for the financial year…
Read the full analysis - Arvaya Healthcare Limited Announces 41st AGM and Proposes Material Related Party Transaction for IP AcquisitionAGM/EGMmedium impact
Cruxal's analysis: Arvaya Healthcare Limited has scheduled its 41st Annual General Meeting for 21 September…
Read the full analysis - Arvaya Healthcare Ltd schedules 41st Annual General Meeting for September 21, 2026Company Updatelow impact
Cruxal's analysis: Arvaya Healthcare Ltd has published a newspaper advertisement announcing its 41st Annual…
Read the full analysis - Arvaya Healthcare Limited approves acquisition of Intellectual Property portfolio from related party for 10 crore INRBoard Meetingmedium impact
Cruxal's analysis: Arvaya Healthcare Limited has announced the board-approved acquisition of a Copyright and…
Read the full analysis - Arvaya Healthcare Limited to consider acquisition of Navahmedi Solution Private Limited via slump saleBoard Meetingmedium impact
Cruxal's analysis: Arvaya Healthcare Limited has announced a board meeting scheduled for August 26, 2026, to…
Read the full analysis - Arvaya Healthcare Ltd initiates shifting of registered office from Assam to MaharashtraCompany Updatelow impact
Cruxal's analysis: Arvaya Healthcare Ltd has issued a formal intimation regarding the shifting of its…
Read the full analysis - Arvaya Healthcare Limited shareholders approve acquisition of Sushodha Institute of Gastroenterology and preferential share issuanceAGM/EGMhigh impact
Cruxal's analysis: Arvaya Healthcare Limited has successfully passed six resolutions via postal ballot, most…
Read the full analysis - Arvaya Healthcare Limited Reports Q1 FY2027 Financial Results with Net Profit of 53.00 croreCompany Updatehigh impact
Cruxal's analysis: Arvaya Healthcare Limited has released its unaudited financial results for the quarter…
Read the full analysis - Arvaya Healthcare Ltd to incorporate a new wholly-owned private limited subsidiaryCompany Updatelow impact
Cruxal's analysis: Arvaya Healthcare Ltd has announced its intention to incorporate a new wholly-owned…
Read the full analysis - Arvaya Healthcare Ltd files Annual Secretarial Compliance Report for FY 2025-26Company Updatelow impact
Cruxal's analysis: Arvaya Healthcare Ltd has submitted its Annual Secretarial Compliance Report for the…
Read the full analysis - Arvaya Healthcare Ltd reports non-applicability of Statement of Deviation for Q1 FY2027Company Updatelow impact
Cruxal's analysis: Arvaya Healthcare Ltd has formally disclosed that the Statement of Deviation or Variation…
Read the full analysis - Arvaya Healthcare Reports Q1 FY27 Results, Approves Material Related Party Transactions, and Plans Insurance Broking SubsidiaryBoard Meetinghigh impact
Cruxal's analysis: Arvaya Healthcare Limited reported consolidated revenue of 29.91 crore for the quarter…
Read the full analysis - Arvaya Healthcare Limited schedules Board Meeting for August 12, 2026, to approve Q1 FY27 financial results and key corporate appointmentsBoard Meetinglow impact
Cruxal's analysis: Arvaya Healthcare Limited has announced a board meeting scheduled for August 12, 2026…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.